Contents and sources 1 sections
Key points
- Nasdaq had scheduled the listing for November 5; Canary confirmed exchange-traded access that day.
INJC listing
Canary Capital’s Canary Staked INJ ETF listed on Nasdaq on November 5 under the ticker INJC. Nasdaq had announced the listing date the previous day. In a post at 3:00 p.m. UTC on November 5 (11:00 p.m. in Taipei), Canary confirmed that INJC offers exchange-traded exposure to INJ with potential staking rewards.[1][2]
The product holds INJ to provide price exposure after expenses, with a secondary objective of earning additional INJ by validating transactions on Injective’s proof-of-stake network. Staking rewards are reflected in daily net asset value rather than paid directly to investors. The product is not registered under the U.S. Investment Company Act of 1940 and does not have the same protections as funds registered under that law. Investors could lose their entire investment.[1][3]
Sources & further reading
(4)
When checking a claim, compare the source date, measurement period and conditions. Some linked pages change over time.
- Canary Capital announces exchange-traded INJ access (opens in a new tab)
- Nasdaq to Begin Listing Canary Staked INJ ETF on Thursday, November 5, 2026 (opens in a new tab)
- Canary Staked INJ ETF — investment objectives and risks (opens in a new tab)
- Odaily newsflash 531241 — RSS discovery only (opens in a new tab)
For information and education, not investment advice. Crypto assets are volatile. Verify independently.
